June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Prevalence of chorioretinitis in Mycobacterium chimera endocarditis and disseminated disease
Author Affiliations & Notes
  • Travis Mitchell
    Ophthalmology, University of Kansas Medical Center Department of Internal Medicine, Kansas City, Kansas, United States
  • Aaron Veenis
    Ophthalmology, University of Kansas Medical Center Department of Internal Medicine, Kansas City, Kansas, United States
  • Mary Champion
    Ophthalmology, University of Kansas Medical Center Department of Internal Medicine, Kansas City, Kansas, United States
  • Radwan Ajlan
    Ophthalmology, University of Kansas Medical Center Department of Internal Medicine, Kansas City, Kansas, United States
  • Footnotes
    Commercial Relationships   Travis Mitchell None; Aaron Veenis None; Mary Champion None; Radwan Ajlan None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3748. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Travis Mitchell, Aaron Veenis, Mary Champion, Radwan Ajlan; Prevalence of chorioretinitis in Mycobacterium chimera endocarditis and disseminated disease. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3748.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Mycobacterium chimera is a cause of endocarditis and disseminated infections that is increasing in occurrence and has been documented to cause chorioretinitis. One paper involved examining 5 patients with M. chimera endocarditis and every patient had chorioretinal lesions, but larger scale data does not exist. We performed a cross-sectional study to check for prevalence rates in 26 patients with M. chimera endocarditis and disseminated disease.

Methods : This is a cross sectional study examining prevalence of M. chimera chorioretinitis in patients with M. chimera endocarditis and disseminated disease. 26 patients with M. chimera infections were reviewed for a diagnosis of chorioretinitis.

Results : Of the 26 patients with M. chimera infection, 5 were diagnosed with chorioretinitis for a prevalence rate of 19.2%.

Conclusions : From our study group the prevalence rate of chorioretinitis in M. chimera endocarditis was 19.2%. This number is likely low as these patients are not screened for visual symptoms and critically ill, a prospective screening study would better define the true prevalence rate.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×